CiloTax StentTM - summitMD.com

More documents

Recommendations

Info

Results Systemic drug levels and out<strong>com</strong>es during follow-up • Cilostazol & taxol were not detectable systemically by HPLC method. • There were no stent thrombosis or death during 1-month follow-up.
Results 3.0 18mm Cilotax BMS 4 weeks Follow-up 3.0 18mm
Page 1 and 2: CiloTax Stent TM Dual Drug-eluting
Page 3 and 4: Moving Forward Co-drug Eluting Sten
Page 5 and 6: A Potent Anti-platelet Agent Effect
Page 7 and 8: Anti-restenotic Effect DECLARE - Lo
Page 9 and 10: The Ideal Combination? Cilotax TM S
Page 11 and 12: Cilotax Stent TM Polymer & Drugs Po
Page 13 and 14: Safety and Efficacy of the Cilotax
Page 15 and 16: Animal Preparation • Juvenile swi
Page 17: Analysis • Angiography and IVUS:
Page 21 and 22: IVUS Analysis at Follow-Up (n=7) BM
Page 23 and 24: Results BMS (n=3) Cilotax stent (n=
Page 25 and 26: Results Inflammatory Response BMS (
Page 27 and 28: Clinical Study Efficacy and Safety
Page 29 and 30: Objectives • to assess safety and
Page 31 and 32: Study Endpoints • Statistics - a

CiloTax StentTM - summitMD.com

Create successful ePaper yourself

Delete template?

Save as template?